The uptake of recombinant glucocerebrosidases by blood monocytes from type 1 Gaucher disease patients is variable

被引：11

作者：

Berger, Juliette ^{[1
]}

Stirnemann, Jerome ^{[2
]}

Bourgne, Celine ^{[1
]}

Pereira, Bruno ^{[3
]}

Pigeon, Pascale ^{[1
]}

Heraoui, Djazia ^{[4
]}

Froissart, Roseline ^{[5
]}

Rapatel, Chantal ^{[1
]}

Rose, Christian ^{[6
]}

Belmatoug, Nadia ^{[4
]}

Berger, Marc G. ^{[1
]}

机构：

[1] CHU Estaing, Clermont Ferrand, France

[2] CHU Jean Verdier, AP HP, Bondy, France

[3] CHU G Montpied, DRCI, Clermont Ferrand, France

[4] Hop Beaujon, AP HP, Clichy, France

[5] Grp Hosp Est, Ctr Biol Est, Lab Malad Hereditaires Metab, Bron, France

[6] Hop St Vincent de Paul, Lille, France

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2012年 / 157卷 / 02期

关键词：

monocyte; Gaucher disease; enzyme replacement therapy; ENZYME REPLACEMENT THERAPY;

D O I：

10.1111/j.1365-2141.2011.08989.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：274 / 277

页数：4

共 10 条

[1] Glucocerebrosidase deficiency dramatically impairs human bone marrow haematopoiesis in an in vitro model of Gaucher disease [J].

Berger, Juliette ;

Lecourt, Severine ;

Vanneaux, Valerie ;

Rapatel, Chantal ;

Boisgard, Stephane ;

Caillaud, Catherine ;

Boiret-Dupre, Nathalie ;

Chomienne, Christine ;

Marolleau, Jean-Pierre ;

Larghero, Jerome ;

Berger, Marc G. .

BRITISH JOURNAL OF HAEMATOLOGY, 2010, 150 (01) :93-101

[2] Marked elevation of the chemokine CCL18/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention [J].

Boot, RG ;

Verhoek, M ;

de Fost, M ;

Hollak, CEM ;

Maas, M ;

Bleijlevens, B ;

van Breemen, MJ ;

van Meurs, M ;

Boven, LA ;

Laman, JD ;

Moran, MT ;

Cox, TM ;

Aerts, JMFG .

BLOOD, 2004, 103 (01) :33-39

[3] Characterization of gene-activated human acid-β-glucosidase: Crystal structure, glycan composition, and internalization into macrophages [J].

Brumshtein, Boris ;

Salinas, Paul ;

Peterson, Brian ;

Chan, Victor ;

Silman, Israel ;

Sussman, Joel L. ;

Savickas, Philip J. ;

Robinson, Gregory S. ;

Futerman, Anthony H. .

GLYCOBIOLOGY, 2010, 20 (01) :24-32

[4]

Edmunds T, 1998, DEV BIOL STAND, V96, P131

[5]

Friedman BA, 1999, BLOOD, V93, P2807

[6] Production of glucocerebrosidase with terminal mannose glycans for enzyme replacement therapy of Gaucher's disease using a plant cell system [J].

Shaaltiel, Yoseph ;

Bartfeld, Daniel ;

Hashmueli, Sharon ;

Baum, Gideon ;

Brill-Almon, Einat ;

Galili, Gad ;

Dym, Orly ;

Boldin-Adamsky, Swetlana A. ;

Silman, Israel ;

Sussman, Joel L. ;

Futerman, Anthony H. ;

Aviezer, David .

PLANT BIOTECHNOLOGY JOURNAL, 2007, 5 (05) :579-590

[7] Impact of imiglucerase on the serum glycosylated-ferritin level in Gaucher disease [J].

Stirnemann, Jerome ;

Boutten, Anne ;

Vincent, Corine ;

Mekinian, Arsene ;

Heraoui, Djazia ;

Fantin, Bruno ;

Fain, Olivier ;

Mentre, France ;

Belmatoug, Nadia .

BLOOD CELLS MOLECULES AND DISEASES, 2011, 46 (01) :34-38

[8] Effect of mannose chain length on targeting of glucocerebrosidase for enzyme replacement therapy of Gaucher disease [J].

Van Patten, Scott M. ;

Hughes, Heather ;

Huff, Michael R. ;

Piepenhagen, Peter A. ;

Waire, James ;

Qiu, Huawei ;

Ganesa, Chandrashekar ;

Reczek, David ;

Ward, Paul V. ;

Kutzko, Joseph P. ;

Edmunds, Tim .

GLYCOBIOLOGY, 2007, 17 (05) :467-478

[9] Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: A report from the Gaucher Registry [J].

Weinreb, NJ ;

Charrow, J ;

Andersson, HC ;

Kaplan, P ;

Kolodny, EH ;

Mistry, P ;

Pastores, G ;

Rosenbloom, BE ;

Scott, CR ;

Wappner, RS ;

Zimran, A .

AMERICAN JOURNAL OF MEDICINE, 2002, 113 (02) :112-119

[10] A pharmacokinetic analysis of a novel enzyme replacement therapy with Gene-Activated® human glucocerebrosidase (GA-GCB) in patients with type 1 Gaucher disease [J].

Zimran, Ari ;

Loveday, Kenneth ;

Fratazzi, Candida ;

Elstein, Deborah .

BLOOD CELLS MOLECULES AND DISEASES, 2007, 39 (01) :115-118

← 1 →